Personalized AI-designed medicine stories will repeat until it's n=10 billion.

Personalized AI-designed medicine stories will repeat until it's n=10 billion. | This is going to happen as n equals 1 over and over again until it's n= 10 billion.

This is going to happen as n equals 1 over and over again until it's n= 10 billion.

Beneficiaries (23)

Adverse (6)

{
  "nia": false,
  "qty": "n=10 billion treated",
  "url": "https://www.youtube.com/watch?v=LVvleNtllPk",
  "mode": "PREDICTION",
  "role": "Host",
  "context": "This is going to happen as n equals 1 over and over again until it's n= 10 billion.",
  "to_year": 2026,
  "verbatim": "This is going to happen as n equals 1 over and over again until it's n= 10 billion.",
  "conv_cues": "is going to happen",
  "direction": "NUMERIC_TARGET",
  "from_year": 2026,
  "timeframe": "future",
  "conv_level": "HIGH",
  "milestones": [
    {
      "kind": "llm_pre_event",
      "label": "Rentosertib (ISM001-055) becomes first AI-designed drug to receive INN",
      "notes": "HIT — Foundational milestone. AI-designed drug acceptance by drug-naming authority.",
      "source": "Mayo Clinic Proceedings — Individualized Medicine in the Era of AI",
      "status": "hit",
      "weight": 0.4,
      "ordinal": -9,
      "source_id": null,
      "confidence": 0.95,
      "source_url": "https://www.mayoclinicproceedings.org/article/S0025-6196(25)00417-3/fulltext",
      "expected_date": "2025-03-15",
      "observed_date": "2025-03-15",
      "hit_emitted_at": "2026-06-08T22:11:23.030711+00:00",
      "research_origin": "deep_research",
      "measurement_criterion": "Insilico Medicine's AI-designed candidate receives official International Nonproprietary Name (INN) from WHO"
    },
    {
      "kind": "llm_pre_event",
      "label": "BenevolentAI partners with major pharma on patient-population-specific drugs",
      "notes": "HIT — BenevolentAI confirmed partnerships with major pharma for population-specific drug design.",
      "source": "Frontiers in Medicine — The expanding role of AI in personalised medicine",
      "status": "hit",
      "weight": 0.4,
      "ordinal": -8,
      "source_id": null,
      "confidence": 0.85,
      "source_url": "https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1795879/full",
      "expected_date": "2025-07-02",
      "observed_date": "2025-09-30",
      "hit_emitted_at": "2026-06-08T22:11:23.030711+00:00",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2025-12-31",
        "from": "2025-01-01"
      },
      "measurement_criterion": "BenevolentAI announces partnership/program developing drugs tailored to specific patient genetic markers"
    },
    {
      "kind": "llm_pre_event",
      "label": "Insilico Chemistry42 candidates in clinical trials",
      "notes": "HIT — Validates 'n=1 AI design → trials' progression.",
      "source": "Frontiers in Medicine; Intuz industry analysis",
      "status": "hit",
      "weight": 0.4,
      "ordinal": -7,
      "source_id": null,
      "confidence": 0.9,
      "source_url": "https://www.intuz.com/blog/generative-ai-in-precision-medicine",
      "expected_date": "2025-07-02",
      "observed_date": "2025-06-30",
      "hit_emitted_at": "2026-06-08T22:11:23.030711+00:00",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2025-12-31",
        "from": "2025-01-01"
      },
      "measurement_criterion": "Insilico Medicine reports multiple AI-designed candidates (e.g. fibrosis program) in active clinical trials"
    },
    {
      "kind": "prereq",
      "label": "Nvidia quadrupled chip production output while only doubling human headcount — achieved by deploying AI coding tools (Cursor, Claude Code) a",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -6,
      "source_id": "SEM_012",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29",
      "hit_emitted_at": "2026-06-08T22:11:23.030711+00:00"
    },
    {
      "kind": "prereq",
      "label": "Training runs costing $10 billion for a single model will commence sometime in 2025.",
      "status": "hit",
      "weight": 0.5,
      "ordinal": -5,
      "source_id": "SEM_008",
      "expected_date": "2026-04-29",
      "observed_date": "2026-04-29",
      "hit_emitted_at": "2026-06-08T22:11:2
... (truncated)